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ABSTRACT
The efficacy of Ivermectin was evaluated under field conditions at Nyala town, South Darfur State, Sudan. 
The study involved 16 donkeys. Ivermectin was administered by intramuscular injection at dose of 0.2 mg/kg in 
the lateral mid- line of the neck. Treatment efficacy was based on the mean faecal egg count reduction 14 days 
post treatment. A faecal egg count reduction of 100% was found after treatment with Ivermectin. In addition 
efficacy percentages of Ivermectin against immature and adult nematodes were as follows: Trichostrongylus axei 
100%, Parascaris equorum 100%, Oxyuris equi 100%, Triodontophorus sp. 100%, Strongylus sp. 100%, and 
small strongyles 100%. Two of the control donkeys were infected with Strongylus vulgaris larvae. Ivermectin 
showed moderate efficacy (69.23%) against larvae found in the mesenteric artery aneurisms. No adverse reactions 
were observed during the experimental period.
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Introduction
Donkeys are becoming increasingly important animals in the Sudan given the new 
socio-economic situation with an increased use of donkeys instead of horses in labour and 
transportation. Nematode infection was the main problem reported in donkeys admitted to 
veterinary clinics (ALI et al., 2001). Ivermectin "ivomec" is a potent agent, active against 
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many external and internal parasites in domestic animals. Ivermectin is today the elixir in 
the world of parasite chemotherapy. It is vogue and highly effective with a wide margin 
of activity and safety. In equines, a variety of adverse reactions have been reported in 
horses after parenteral administration of Ivermectin at the recommended dosage of 0.2 
mg/kg body weight (FRENCH et al., 1983; LEANING, 1983; REED, 1983). These reactions 
have occurred in a small percentage of treated horses and the drug is now sold only as a 
paste for oral administration. Ivermectin has an excellent efficacy for an important range 
of gastrointestinal nematodes of equines (CAMPBELL et al., 1989).  Although not registered 
for use in donkeys, Ivermectin injection is currently used by many donkey owners who 
are claiming excellent results and no adverse side-effects. The aim of this study was to 
investigate the therapeutic efficacy of Ivermectin introduced intramuscularly as an injectable 
formulation to donkeys harbouring natural gastrointestinal nematodes.
Materials and methods
Study animals. This study involved 16 donkeys, aging 3-10 years. The donkeys had 
naturally acquired mixed parasitic infections, comprising gastrointestinal nematodes. 
Infections were confirmed before the beginning of the study by egg flotation and the 
parasites were identified after performing larval culture. Individual egg count was 
determined by using a modified McMaster technique (ANON., 1986). After treatment, 
experimental animals were penned by treatment groups until the end of the observation 
period. The animals were kept on tap water and straw ad libitum. 
Design of study. Faecal samples were collected from all donkeys and analyzed the 
same day using a modified McMaster technique with a sensitivity of 50 EPG (egg per gram 
of faeces). Animals were weighed and treated as follows: Ivermectin – treated group1 
(IVMT) (14 animals) received a single intramuscular injection of 200 mcg/kg Ivermectin 
(Ivermectin 10® injection, ANUPco. England). Injection was administered in the lateral 
mid- line of the neck. The remaining two animals were kept untreated as control animals 
(intended for slaughtering). Donkeys were then observed for possible adverse reactions 
for 2 hours after injection. Faecal egg counts were performed on each animal daily for the 
first week and then on days 14, 21 and 28.  On each of days 15, 16, 17, and 18 two animals 
(one per each day) from each group (control and IVMT) were killed and necropsied. Day 
of slaughter for each animal had been determined on day zero by random assignment at 
the same time as donkeys were allocated to treatment groups. Animals were slaughtered 
and methods used for worm recovery were the same as those previously described by 
(REINECKE and LE ROUX, 1972). Helminthes were identified at a later stage by placing 
them on glass slides, examining them microscopically and classifying them using the early 
description (LICHTENFELS, 1975).  
Data analysis. The faecal egg count reduction (FECR) test was used to determine the 
anthelmintic efficacy. Each animal acted as its own control. Arithmetic means of the egg 
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counts and nematode burdens were calculated to determine the mean percentage reductions, 
according to the following formula:
Results and discussion
Faecal egg count reductions. The results of day zero to day 28 mean EPG values 
are presented in Table 1, together with the mean faecal egg count reductions. Ivermectin 
produced 100% reduction of nematode eggs on day 7 onwards. On day 0 all donkeys had 
positive egg counts with a range of 100-5150 EPG. On day 14, at IVMT all donkeys had 
negative egg counts to the end of the experiment. 
Table. Mean faecal egg counts (± SD) and reductions for Ivermectin - treated donkeys
Day Arithmetic mean (EPG) Range Mean% reduction
0  1545.0 ± 1589.6 100 - 5150 -
1 1270.0 ± 545.3 650 - 2400 17.80%
2  744.4 ± 1015.9    0 - 3300 51.82%
3 195.0 ± 279.3   0 - 800 87.38%
4 20.0 ± 35.0   0 - 100 98.71%
5 15.0 ± 24.2 0 - 50 99.03%
6 5.0 ± 15.8   0 - 500 99.68%
7 0.0 ± 0.0 0 - 0 100%
14 0.0 ± 0.0 0 - 0 100%
21 0.0 ± 0.0 0 - 0 100%
28 0.0 ± 0.0 0 - 0 100%
Postmortem findings. The results of postmortem findings and the nematodes collected 
were present in Table 2. The results obtained indicated that animals received Ivermectin 
intramuscularly showed zero nematode burdens except for the larval stages of Strongylus 
vulgaris larvae (L4) present in the cranial mesenteric artery. In the trunk of the cranial 
mesenteric artery (and its main branches), in the iliac, celiac, femoral arteries larvae cause 
inflammation of the arterial wall, formation of thrombuses, thickening and dilatation of 
the wall of arteries, aneurysms.  
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Table. Summary of worms recovered from control and treated animals with Ivermectin at 





Strongylus vulgaris 130 40 69.23
Stomach
Gastrophilus sp. 667 0 100
Habronema sp. 320 0 100
Trichostrongylus axei 50 0 100
Small Intestine
Parascaris equorum 10 0 100
Caecum
Gastrophilus sp. 30 0 100
Strongylus sp. 820 0 100
Cyathostomes sp. 1000 0 100
Colon
Strongylus sp. 3360 0 100
Cyathostomes sp. 




Gastrophilus sp. 110 0 100
Oxyuris equi 20 0 100
Discussion
In this study, a 100% reduction in faecal egg count was shown at IVMT animals after 
administration of Ivermectin by intramuscular injection. This finding is in accordance with 
other findings in horses (COSTA et al., 1998; DAVIES and SCHWALBACH, 2000). Doramectin, 
an avermectin currently registered for use in sheep, cattle and swine also produced 100% 
efficacy when administered to donkeys in Sudan (SERI et al., 2004)., and to horses in South 
Africa (DAVIES and SCHWALBACH, 2000). These findings indicate that Ivermectin appears 
to be effective against adult Cyathostomes, Strongylus spp., Trichostrongylus axei and 
Parascaris equorum in donkeys. 
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In this study, the presence of some Strongylus vulgaris larvae in the animals treated 
with Ivermectin intramuscularly indicated incomplete activity against arterial stages of 
Strongylus vulgaris as Ivermectin showed only (69.23%) efficacy against arterial stages. 
This result is in agreement with that of (COSTA et al., 1998) who reported (67.8%) efficacy 
of Ivermectin against Strongylus vulgaris larvae found in the mesenteric artery aneurisms. 
No adverse reactions were observed such as irritation or swelling at the injection site in 
any of the treated donkeys. 
The fact that Ivermectin may be administered by intramuscular injection ensures that 
no anthelmintic is wasted hence no under dosing occurs, providing the animal weight is 
accurately determined. Under- dosing has been suggested as an important factor in hastening 
the development of resistance  (PRICHARD, 1990) and this is often a risk associated with 
oral dosing, as spillage frequently occurs. 
Conclusion 
A single intramuscular injection of Ivermectin administered at a dose rate of 0.2 
mg/kg body weight was highly efficient against naturally acquired infections of adult 
Cyathostomes, Strongylus spp., Trichostrongylus axei, Parascaris equorum, Oxyuris 
equi and Triodontophorus spp.; gastrointestinal nematodes in donkeys. These findings 
suggest that further research into the use of Ivermectin injectable formulation as an equine 
anthelmintic might be warranted.
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SAŽETAK
Procjenjivana je djelotvornost ivermektina u terenskim uvjetima u gradu Nyala, Južni Darfur, Sudan. 
Istraživanje je provedeno na 16 magaraca. Ivermektin je bio primijenjen intramuskularnim injekcijama u dozi od 
0,2 mg/kg u lateralnu stranu vrata. Ocjena učinkovitosti lijeka provedena je na temelju smanjenja ukupnog broja 
jaja u fecesu 14 dana poslije liječenja. Ukupni broj jaja u fecesu smanjio se za 100% poslije primjene ivermektina. 
Nadalje, postotci djelotvornosti ivermektina protiv nezrelih i adultnih stadija oblića bili su: Trichostrongylus axei 
100%, Parascaris equorum 100%, Oxyuris equi 100%, Triodontophorus sp. 100%, Strongylus sp. 100% i mali 
strongilidi 100%. Dva kontrolna magarca bila su invadirana ličinkama Strongylus vulgaris. Ivermektin je bio 
umjereno djelotvoran (69,23%) protiv ličinki nađenih u aneurizmama mezenterijalnih arterija. Tijekom pokusa 
nisu zamijećene štetne posljedice liječenja.
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